CSIMarket
 


Clovis Oncology inc   (CLVS)
Other Ticker:  
 
 

CLVS's Free Cash Flow Growth by Quarter and Year

Clovis Oncology Inc 's Free Cash Flow results by quarter and year




CLVS Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -41.34 -56.05 -70.15
III Quarter September -40.61 -46.07 -54.32 -56.98
II Quarter June -35.13 -46.76 -59.86 -98.04
I Quarter March -58.50 -61.89 -82.49 -98.45
FY   -134.24 -196.06 -252.72 -323.62



CLVS Free Cash Flow third quarter 2022 Y/Y Growth Comment
Clovis Oncology inc in the third quarter 2022 recorded free cash outflow of $ -40.61 millions.

According to the results reported in the third quarter 2022, Clovis Oncology Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Clovis Oncology Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2022.




CLVS Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Clovis Oncology Inc 's third quarter 2022 Free Cash Flow $ -40.61 millions CLVS's Income Statement
Clovis Oncology Inc 's third quarter 2021 Free Cash Flow $ -46.07 millions Quarterly CLVS's Income Statement
New: More CLVS's historic Free Cash Flow Growth >>


CLVS Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Clovis Oncology Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLVS's III. Quarter Q/Q Free Cash Flow Comment
Current free cash outflow of -40.61 millions by Clovis Oncology inc appear even less good if you take a look at free cash outflow -35.13 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Clovis Oncology inc achieved highest sequential Free Cash Flow growth. While Clovis Oncology Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLVS's III. Quarter Q/Q Free Cash Flow Comment
III. Quarter 2022 results of -40.61 millions by Clovis Oncology inc come out even worse compare to the -35.13 millions free cash outflow a quarter before.

Within Major Pharmaceutical Preparations industry Clovis Oncology inc achieved highest sequential Free Cash Flow growth. While Clovis Oncology Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Clovis Oncology Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Free Cash Flow 12 Months Ending $ -175.31 $ -180.77 $ -192.41 $ -195.75 $ -210.26
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


Clovis Oncology inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


Clovis Oncology inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
CLVS's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for CLVS's Competitors
Free Cash Flow Growth for Clovis Oncology Inc 's Suppliers
Free Cash Flow Growth for CLVS's Customers

You may also want to know
CLVS's Annual Growth Rates CLVS's Profitability Ratios CLVS's Asset Turnover Ratio CLVS's Dividend Growth
CLVS's Roe CLVS's Valuation Ratios CLVS's Financial Strength Ratios CLVS's Dividend Payout Ratio
CLVS's Roa CLVS's Inventory Turnover Ratio CLVS's Growth Rates CLVS's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2022
Avantor Inc -1.37%$ -1.375 millions
Ensign Group Inc-3.71%$ -3.713 millions
Abbvie inc -4.20%$ -4.197 millions
Stryker Corp-4.72%$ -4.716 millions
Select Medical Holdings Corp-4.74%$ -4.741 millions
Prestige Consumer Healthcare Inc -5.97%$ -5.971 millions
Utah Medical Products Inc-6.71%$ -6.710 millions
Mettler toledo International Inc -6.79%$ -6.789 millions
Dynavax Technologies Corporation-7.02%$ -7.025 millions
Ironwood Pharmaceuticals inc -7.96%$ -7.957 millions
Luna Innovations Inc-7.98%$ -7.979 millions
Quest Diagnostics Inc-10.52%$ -10.517 millions
Reflect Scientific Inc -10.82%$ -10.823 millions
Horizon Therapeutics Public Limited Company-10.84%$ -10.845 millions
West Pharmaceutical Services Inc -11.15%$ -11.152 millions
Bionexus Gene Lab Corp -11.24%$ -11.239 millions
Gilead Sciences Inc -11.99%$ -11.989 millions
Progyny Inc -13.53%$ -13.529 millions
Organon and Co -13.86%$ -13.859 millions
Sotera Health Company-16.26%$ -16.258 millions
Nuvasive Inc-17.01%$ -17.008 millions
Atrion Corporation-17.09%$ -17.090 millions
Integra Lifesciences Holdings Corp-17.48%$ -17.475 millions
Biogen Inc -17.92%$ -17.919 millions
3m Company-18.30%$ -18.303 millions
Zoetis Inc -19.45%$ -19.449 millions
Viatris Inc -19.95%$ -19.952 millions
Teleflex Incorporated-23.10%$ -23.103 millions
Intuitive Surgical Inc -23.57%$ -23.574 millions
Align Technology inc -24.94%$ -24.935 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com